Cerus' blood-safety system meets main goal in late-stage trial

Cerus Corp said on Monday a late-stage study showed that red blood cells treated ​with its blood-safety technology performed as ‌well as conventional red blood cells in patients…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)